More Globe Newswire

View Older Stories View Newer Stories

Jun 1, 2026 01:00AM BNP PARIBAS PRESENTS THE GROWTH STRATEGY OF ITS COMMERCIAL BANK IN BELGIUM (CPBB) AND RAISES ITS PROFITABILITY TARGETS TO 22% PRE-TAX RONE IN 2028 AND 25% IN 2030
Jun 1, 2026 01:00AM IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production
Jun 1, 2026 01:00AM Aktsiaselts Infortar own share acquisition transactions
Jun 1, 2026 01:00AM Roche to present new data advancing its obesity portfolio at the American Diabetes Association’s 2026 Scientific Sessions
Jun 1, 2026 01:00AM Construction contract in Estonia (main building of the Krulli Quarter in Tallinn)
Jun 1, 2026 12:59AM NVIDIA, Foxconn and Taiwan Medical Centers Bring Agentic and Physical AI to ‘Healthy Taiwan’
Jun 1, 2026 12:53AM NVIDIA Releases Major Collection of Open Source Agent Tools and Skills for Physical AI
Jun 1, 2026 12:50AM NVIDIA Announces NVIDIA Isaac GR00T Reference Humanoid Robot for Academic Research
Jun 1, 2026 12:48AM NVIDIA DRIVE Hyperion Becomes the Global Platform for a Robotaxi-Ready World
Jun 1, 2026 12:46AM NVIDIA Launches Alpamayo 2 Super Open Reasoning Model for Robotaxis
Jun 1, 2026 12:42AM NVIDIA Launches Cosmos 3, the Open Frontier Foundation Model for Physical AI
Jun 1, 2026 12:35AM NVIDIA DGX Station for Windows Puts a Trillion-Parameter AI Supercomputer on Every Enterprise Desk
Jun 1, 2026 12:26AM NVIDIA and Microsoft Reinvent Windows PCs for the Age of Personal AI
Jun 1, 2026 12:21AM Enterprise Software Leaders Build AI Agents With NVIDIA
Jun 1, 2026 12:01AM NIO Inc. Provides May 2026 Delivery Update
May 31, 2026 11:57PM NVIDIA Unveils Vera, the CPU for Agents
May 31, 2026 11:47PM NVIDIA Vera BlueField-4 STX Brings Agentic AI Storage Processing With In-Silicon Security
May 31, 2026 11:43PM NVIDIA Vera Rubin Ramps Into Full Production to Power Agentic AI Factories Worldwide
May 31, 2026 11:30PM NVIDIA DSX Gives Infrastructure Builders the Playbook for AI Factories
May 31, 2026 10:00PM Crypto Meets Wall Street: MEXC Unveils 'RealStocks' with 0-Fee U.S. Equity Trading and Real Dividends
May 31, 2026 10:00PM Crypto Meets Wall Street: MEXC Unveils 'RealStocks' with 0-Fee U.S. Equity Trading and Real Dividends
May 31, 2026 09:44PM Crypto News Today: AlphaPepe Presale Hits $1.43M While Ethereum Price Prediction Eyes $10K
May 31, 2026 09:43PM Topicus.com Inc. Announces a Revised Proposal to Acquire ReadyTech
May 31, 2026 07:59PM BriaCell Therapeutics Announces Pricing of Offering
May 31, 2026 07:30PM Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
May 31, 2026 07:30PM Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
May 31, 2026 07:30PM Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
May 31, 2026 07:30PM Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
May 31, 2026 07:01PM Viva! Marks World Milk Day by Announcing Major Dairy Documentary
May 31, 2026 02:52PM Diana Shipping Inc. Sends Letter to Genco Shipping & Trading Shareholders Making the Case for Electing Six Independent Nominees With Proven Track Records of Creating Shareholder Value
May 31, 2026 02:52PM Diana Shipping Inc. Sends Letter to Genco Shipping & Trading Shareholders Making the Case for Electing Six Independent Nominees With Proven Track Records of Creating Shareholder Value
May 31, 2026 02:29PM UGRO: urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 Player Auction Set for June 1, 2026 @ 5:00 AM EDT (2:30 PM Colombo Time)
May 31, 2026 12:06PM CGTN: China-Africa ties at 70: From shared struggles to a common dream of modernization
May 31, 2026 11:54AM Sublime AI Law Mastery Unveiled to Resolve Historic Camp Lejeune Backlog (Veterans First For America)
May 31, 2026 10:04AM KALDVIK AS (KLDVK): Q1 2026 Quarterly Update
May 31, 2026 10:00AM Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
May 31, 2026 09:00AM Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
May 31, 2026 08:25AM AI Is Reshaping Crypto Faster Than Anyone Expected as AIX Alpha’s New System Signals the Shift
May 31, 2026 08:06AM Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic
May 31, 2026 08:00AM Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
May 31, 2026 08:00AM Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 31, 2026 06:00AM NeuExcell Therapeutics Announces Encouraging Data of NXL-004 in Recurrent Malignant Glioma at 2026 ASCO
May 31, 2026 06:00AM Nokia Corporation - Managers' transactions (Hanrahan)
May 31, 2026 01:15AM Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
May 30, 2026 11:29PM Solana Unchained Outlines Fixed-Supply Utility Architecture and AI Tool Hub Ahead of Late May Public Allocation Launch
May 30, 2026 08:30PM Crypto News Today: AlphaPepe Hits $1.38M Raised While Bitcoin Price Prediction Targets $250K
May 30, 2026 06:13PM National Champions are Honoured at the Closing Ceremony of the Skills Canada National Competition 2026, in Toronto
May 30, 2026 02:30PM Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
May 30, 2026 02:30PM Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
May 30, 2026 02:15PM Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
View Newer Stories View Older Stories